Open original FDA record ↗Recall record
- FDA identifier
- Z-2432-2008
- Company in FDA record
- Remel, Inc
- FDA classification date
- Sep 19, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Faint grey test lines for Cryptosporidium may be visible which may be interpreted as false positive
Source facts
- Action
- The recalling firm issued letters dated 6/19/08 flagged "IMPORTANT PRODUCT INFORMATION" which advised their customers of the issue with the faint grey test lines but did not request any action be taken, such as return or destruction of the affected lot numbers. The recalling firm issued a second letter flagged "IMPORTANT MEDICAL DEVICE CUSTOMER ADVISORY NOTICE" dated 8/11/08 and was issued via regular mail on 8/14/08. This letter asked users to review their inventory for the product lots indicated in the letter, discard all remaining units of this product lot, complete and return the Product Inventory Checklist regardless if they have affected product. A "PRODUCT INVENTORY CHECKLIST" was enclosed to report whether the firm had product to discard and the amount to be replaced.
- Initiated
- 2008-08-11
- Root cause
- Process control
- Terminated
- 2010-01-21
- Distribution
- Worldwide Distribution --- including USA and countries of Canada and U.K.
- Recall number
- Z-2432-2008
- Recall status
- Terminated
- CDRH record ID
- 72732
- FDA classified
- 2008-09-19
- Recall event number
- 49090